Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 3, 2014, Pages 543-551

  Domingues, Marco M ^a   Silva, Patrícia M ^a   Franquelim, Henri G ^a   Carvalho, Filomena A ^a   Castanho, Miguel A R B ^a   Santos, Nuno C ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Atomic force microscopy; Lipopolysaccharide

Indexed keywords

ATOMIC FORCE MICROSCOPY; ESCHERICHIA COLI; PROTEINS;

ANTIMICROBIAL PROTEINS; FLOW CYTOMETRY ANALYSIS; GRAM-POSITIVE BACTERIUM; LIPOPOLYSACCHARIDES; MEMBRANE DEPOLARIZATION; NEGATIVE SURFACE CHARGES; ZETA POTENTIAL MEASUREMENTS;

BACTERIA;

LIPOPOLYSACCHARIDE; OPEBACAN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; PEPTIDE; PLASMA PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; ESCHERICHIA COLI; FLOW CYTOMETRY; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; SURFACE CHARGE; ZETA POTENTIAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ESCHERICHIA COLI INFECTION; HUMAN; METABOLISM; MICROBIOLOGY; RBPI(21); STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ATOMIC FORCE MICROSCOPY; LIPOPOLYSACCHARIDE; RBPI(21);

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; PEPTIDES; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84896543863     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.11.002     Document Type: Article

References (50)

1. Hancock R.E., Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 1999, 43:1317-1323.
2. Hancock R.E., Scott M.G. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 2000, 97:8856-8861.
3. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003, 55:27-55.
4. Yount N.Y., Bayer A.S., Xiong Y.Q., Yeaman M.R. Advances in antimicrobial peptide immunobiology. Biopolymers 2006, 84:435-458.
5. Melo M.N., Ferre R., Castanho M.A.R.B. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 2009, 7:245-250.
6. Melo M.N., Castanho M.A.R.B. Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation. Biochim Biophys Acta 2007, 1768:1277-1290.
7. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 2006, 8:11-26.
8. Weidenmaier C., Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 2008, 6:276-287.
9. Wiese A., Gutsmann T., Seydel U. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. J Endotoxin Res 2003, 9:67-84.
10. De Smet K., Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005, 27:1337-1347.
11. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978, 253:2664-2672.
12. Beamer L.J., Carroll S.F., Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997, 276:1861-1864.
13. Beamer L.J., Carroll S.F., Eisenberg D. The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. Biochem Pharmacol 1999, 57:225-229.
14. Horwitz A.H., Leigh S.D., Abrahamson S., Gazzano-Santoro H., Liu P.S., Williams R.E., et al. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein. Protein Expr Purif 1996, 8:28-40.
15. 21: a translational overview from bench to clinical studies. Curr Protein Pept Sci 2012, 13:611-619.
16. 2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun 1994, 62:259-265.
17. Horwitz A.H., Williams R.E., Liu P.S., Nadell R. Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother 1999, 43:2314-2316.
18. 23) is a universal lipopolysaccharide-binding ligand. Infect Immun 1994, 62:3564-3567.
19. Gazzano-Santoro H., Parent J.B., Grinna L., Horwitz A., Parsons T., Theofan G., et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 1992, 60:4754-4761.
20. 21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000, 356:961-967.
21. 21 protects against pneumococcal disease. Infect Immun 2007, 75:342-349.
22. 21 from transfected CHO-K1 cells. Protein Expr Purif 2000, 18:77-85.
23. 21) in combination with sulfadiazine is active against Toxoplasma gondii. Antimicrob Agents Chemother 1999, 43:758-762.
24. Bauer R.J., White M.L., Wedel N., Nelson B.J., Friedmann N., Cohen A., et al. A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in healthy male volunteers. Shock 1996, 5:91-96.
25. 21 promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes. PLoS One 2009, 4:e8385.
26. 21). Biophys J 2009, 96:987-996.
27. Wiese A., Brandenburg K., Carroll S.F., Rietschel E.T., Seydel U. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry 1997, 36:10311-10319.
28. Wiese A., Brandenburg K., Lindner B., Schromm A.B., Carroll S.F., Rietschel E.T., et al. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 1997, 36:10301-10310.
29. Alves C.S., Melo M.N., Franquelim H.G., Ferre R., Planas M., Feliu L., et al. Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J Biol Chem 2010, 285:27536-27544.
30. Domingues M.M., Santiago P.S., Castanho M.A.R.B., Santos N.C. What can light scattering spectroscopy do for membrane-active peptide studies?. J Pept Sci 2008, 14:394-400.
31. Novo D., Perlmutter N.G., Hunt R.H., Shapiro H.M. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 1999, 35:55-63.
32. Shapiro H.M. Flow cytometry of bacterial membrane potential and permeability. Methods Mol Med 2008, 142:175-186.
33. Barattin R., Voyer N. Chemical modifications of AFM tips for the study of molecular recognition events. Chem Commun (Camb) 2008, 1513-1532.
34. Carvalho F.A., Connell S., Miltenberger-Miltenyi G., Pereira S.V., Tavares A., Ariëns R.A.S., et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano 2010, 4:4609-4620.
35. Carvalho F.A., Santos N.C. Atomic force microscopy-based force spectroscopy-biological and biomedical applications. IUBMB life 2012, 64:465-472.
36. Carvalho F.A., de Oliveira S., Freitas T., Gonçalves S., Santos N.C. Variations on fibrinogen-erythrocyte interactions during cell aging. PLoS One 2011, 6:e18167.
37. Carvalho F.A., Carneiro F.A., Martins I.C., Assunção-Miranda I., Faustino A.F., Pereira R.M., et al. Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins. J Virol 2012, 86:2096-2108.
38. Ratto T.V., Rudd R.E., Langry K.C., Balhorn R.L., McElfresh M.W. Nonlinearly additive forces in multivalent ligand binding to a single protein revealed with force spectroscopy. Langmuir 2006, 22:1749-1757.
39. Bolshakova A.V., Kiselyova O.I., Yaminsky I.V. Microbial surfaces investigated using atomic force microscopy. Biotechnol Prog 2004, 20:1615-1622.
40. Eaton P., Fernandes J.C., Pereira E., Pintado M.E., Xavier Malcata F. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. Ultramicroscopy 2008, 108:1128-1134.
41. Li A., Lee P.Y., Ho B., Ding J.L., Lim C.T. Atomic force microscopy study of the antimicrobial action of Sushi peptides on Gram negative bacteria. Biochim Biophys Acta 2007, 1768:411-418.
42. Meincken M., Holroyd D.L., Rautenbach M. Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli. Antimicrob Agents Chemother 2005, 49:4085-4092.
43. Anderson R.C., Haverkamp R.G., Yu P.L. Investigation of morphological changes to Staphylococcus aureus induced by ovine-derived antimicrobial peptides using TEM and AFM. FEMS Microbiol Lett 2004, 240:105-110.
44. Ubbink J., Schar-Zammaretti P. Probing bacterial interactions: integrated approaches combining atomic force microscopy, electron microscopy and biophysical techniques. Micron 2005, 36:293-320.
45. Silhavy T.J., Kahne D., Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2010, 2:a000414.
46. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994, 8:217-225.
47. 2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem 1987, 262:14891-14894.
48. Hammer K.A., Heel K.A. Use of multiparameter flow cytometry to determine the effects of monoterpenoids and phenylpropanoids on membrane polarity and permeability in staphylococci and enterococci. Int J Antimicrob Agents 2012, 40:239-245.
49. Fournier B., Philpott D.J. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005, 18:521-540.
50. Biswas R., Martinez R.E., Gohring N., Schlag M., Josten M., Xia G., et al. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One 2012, 7:e41415.